Patents by Inventor Peter Liston

Peter Liston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • XIAP THERAPY
    Publication number: 20110318307
    Abstract: The invention features methods, compositions and kits for the treatment of retinal degenerative disorders.
    Type: Application
    Filed: February 23, 2011
    Publication date: December 29, 2011
    Inventors: Robert G. Korneluk, Catherine Tsilfidis, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Patent number: 7776552
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Grant
    Filed: August 3, 2006
    Date of Patent: August 17, 2010
    Assignee: University of Ottawa
    Inventors: Robert G. Korneluk, Alexander E. MacKenzie, Stephen Baird, Peter Liston
  • DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASE
    Publication number: 20090142334
    Abstract: Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids, IAP fragments, and antibodies which specifically bind IAP polypeptides.
    Type: Application
    Filed: April 28, 2008
    Publication date: June 4, 2009
    Applicant: AEGERA THERPEUTICS, INC.
    Inventors: Robert G. Korneluk, Alexander E. Mackenzie, Peter Liston, Stephen Baird, Benjamin K. Tsang, Christine Pratt
  • Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
    Publication number: 20070219360
    Abstract: Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids, IAP fragments, and antibodies which specifically bind IAP polypeptides.
    Type: Application
    Filed: August 25, 2006
    Publication date: September 20, 2007
    Inventors: Robert G. Korneluk, Alexander E. MacKenzie, Peter Liston, Stephen Baird, Benjamin K. Tsang, Christine Pratt
  • Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
    Publication number: 20070203088
    Abstract: Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids, IAP fragments, and antibodies which specifically bind IAP polypeptides.
    Type: Application
    Filed: August 25, 2006
    Publication date: August 30, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Peter Liston, Stephen Baird, Benjamin Tsang, Christine Pratt
  • XAF genes and polypeptides: methods and reagents for modulating apoptosis
    Publication number: 20070202096
    Abstract: The invention provides novel XAF nucleic acid sequences. Also provided are XAF polypeptides, anti-XAF antibodies, and methods for modulating apoptosis and detecting compounds which modulate apoptosis.
    Type: Application
    Filed: August 4, 2006
    Publication date: August 30, 2007
    Inventors: Robert Korneluk, Katsuyuki Tamai, Peter Liston, Alexander MacKenzie
  • XAF genes and polypeptides: methods and reagents for modulating apoptosis
    Publication number: 20070072217
    Abstract: The invention provides novel XAF nucleic acid sequences. Also provided are XAF polypeptides, anti-XAF antibodies, and methods for modulating apoptosis and detecting compounds which modulate apoptosis.
    Type: Application
    Filed: August 4, 2006
    Publication date: March 29, 2007
    Inventors: Robert Korneluk, Katsuyuki Tamai, Peter Liston, Alexander MacKenzie
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070066524
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: August 4, 2006
    Publication date: March 22, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070048772
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: July 26, 2006
    Publication date: March 1, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070042446
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: August 3, 2006
    Publication date: February 22, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070031904
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: July 25, 2006
    Publication date: February 8, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070031903
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: July 25, 2006
    Publication date: February 8, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070027304
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: July 26, 2006
    Publication date: February 1, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070026470
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: July 25, 2006
    Publication date: February 1, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20070026494
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primer and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: July 26, 2006
    Publication date: February 1, 2007
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Mammalian IAP gene family, primers, probes, and detection methods
    Publication number: 20070009971
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; substantially pure polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primers and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: December 22, 2005
    Publication date: January 11, 2007
    Applicant: Aegera Therapeutics, Inc.
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • XIAP therapy
    Publication number: 20060269520
    Abstract: The invention features methods, compositions and kits for the treatment of degenerative disorders.
    Type: Application
    Filed: January 30, 2006
    Publication date: November 30, 2006
    Applicant: Children's Hospital of Eastern Ontario
    Inventors: Robert Korneluk, Catherine Tsilfidis, Peter Liston, Alex MacKenzie, George Robertson, Nathalie Gendron, James Waring, Doug Mahoney
  • Mammalian IAP gene family, primers, probes and detection methods
    Publication number: 20060205021
    Abstract: Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; substantially pure polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primers and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
    Type: Application
    Filed: January 19, 2006
    Publication date: September 14, 2006
    Applicant: Aegera Therapeutics, Inc.
    Inventors: Robert Korneluk, Alexander MacKenzie, Stephen Baird, Peter Liston
  • Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative disease
    Publication number: 20060189563
    Abstract: Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids IAP fragments, and antibodies which specifically bind IAP polypeptides.
    Type: Application
    Filed: March 20, 2006
    Publication date: August 24, 2006
    Inventors: Robert Korneluk, Alexander MacKenzie, Peter Liston, Stephen Baird, Benjamin Tsang, Christine Pratt
  • Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
    Patent number: 7087584
    Abstract: Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids IAP fragments, and antibodies which specifically bind IAP polypeptides.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: August 8, 2006
    Assignee: Aegera Therapeutics Inc.
    Inventors: Robert G. Korneluk, Alexander E. Mackenzie, Peter Liston, Stephen Baird, Benjamin K. Tsang, Christine Pratt